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Abstract
The objective of this project is to examine Process Deviation Reports (PDRs) 
generated from 2006 to 2008 for Sachet Products where “Human Error” has been 
identified as the primary root cause. Sachet Products were chosen for this review as 
they represent the largest volume output, and the production process involves the 
largest number of employees compared to other processes in Rottapharm Ltd. e.g. 
capsule or tablet production processes. For that reason, it was considered that 
Human Error PDRs generated during Sachet production represents the “worst-case- 
scenario” for Human Error PDRs reported at Rottapharm Ltd. From this review, it is 
intended that trends in Sachet Human Error PDRs will be identified and the 
effectiveness of corrective actions implemented will be assessed.
Sachet PDRs reported in 2006, 2007 and 2008 were reviewed. The project reports 
encouraging trends, with the number of PDRs per Sachet output seen to be 
decreasing from 2006 to 2008.
Retraining and document update (e.g. standard operating procedures, checklists, 
training manuals etc.) were the primary corrective actions implemented in the period 
under review. While retraining sessions appear to be effective in the short-term, it is 
recommended that further medium- and long-term solutions must be found to 
address Human Error PDRs, e.g. control and monitoring of processes utilising 
Manufacturing Execution Systems and Process Analytical Technology.
Additional recommendations from this project include increased communication with 
different departments to highlight Human Error trends to improve awareness and 
vigilance to these issues. In addition, the approaches of other Irish Healthcare 
companies in managing Human Error PDRs were reviewed. This concluded that the 
approach in Rottapharm Ltd. is comparable to that of other companies in the Irish 
Healthcare Industry.
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1.0 Introduction
Rottapharm Ltd. is part of the Rotta Research group, which has its 
headquarters in Monza, Italy. The parent company was established in 1960 
and the company is privately owned. The company’s product range is 
primarily in the therapeutic categories of rheumatology, gastroenterology, 
osteoporosis and HRT, and is marketed in 62 countries. The main markets 
are Europe, South America and the Far East. The group has 6 other 
manufacturing plants in Europe and employs approximately 2000 people in 
total. The Irish operation commenced in 1998 and the purpose built facility in 
Mulhuddart, Dublin 15, was opened in June 1999. Rottapharm Ltd. currently 
employs approximately 150 people.
At the Rottapharm Ltd. facility, finished product in the form of capsules and 
sachets are produced primarily for the treatment of osteoarthritis. The Active 
Pharmaceutical Ingredient (API) for these products, Crystalline Glucosamine 
Sulphate, is also produced at the Dublin facility. The other main product 
manufactured at the Dublin site is an anti-inflammatory product in the form of 
tablets, containing the active ingredient Bromelain. Rottapharm Ltd. is also 
responsible for batch release of a Nitroglycerine transdermal patch called 
Epinitril/Dermatrans and two medical devices called “GO-ON®” and “GO-ON® 
Mini”. The Nitroglycerine transdermal patch is manufactured by a 
subcontractor based in Germany. The medical device products are pre-filled 
syringes containing a Sodium Hyaluronate solution, and are manufactured by 
a subcontractor based in Austria.
In 2007, the acquisition of the German Madaus Pharma, who specialized in 
the production of natural pharmaceutics, by the Rottapharm Group 
strengthened a route already undertaken by many of its brands: from natural 
origin to active principle. The Rottapharm Group was renamed as 
Rottapharm|Madaus and change began at Rottapharm Ltd. when the Dublin
1.1 Introduction to Rottapharm Ltd.
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facility was identified as a potential back-up to the Madaus Barcelona facility. 
To enable this, a facility extension was initiated in August 2008 to increase 
capability at the Dublin site. In 2008, Rottapharm Ltd. commenced introduction 
and validation of two new products, Plantaben Sachets and Tromalyt 
Capsules. The introduction of other sachet products utilising the Plantago 
Ovata Active Pharmaceutical Ingredient (the API in Plantaben Sachets) 
include Legalon, Colofibre and Spagulax, which are planned for introduction in 
2009.
The following pharmaceutical activities at Rottapharm Ltd. are licensed by the 
IMB (Licence number M868):
- Non Sterile Operations -  Solid Dosage Forms:
o Single Dose Powders 
o Capsules 
o Tablets
- Manufacturing Operations:
o Manufacture 
o Filling 
o Packaging 
o Storage 
o Testing 
o Distribution
- Other Operations:
o Batch Release of Transdermal Patches
In addition, the IMB provides GMP certificates stating that Rottapharm Ltd. is a 
manufacturer lawfully engaged in the manufacture of the active 
pharmaceutical ingredient Crystalline Glucosamine Sulphate.
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Investigational Medicinal Products are also manufactured at the facility 
(Licence number IMP-017):
- Operations:
o Manufacture 
o Filling 
o Packaging 
o Storage 
o Testing 
o Distribution
The Quality Policy of Rottapharm Ltd. (as stated in Rottapharm Ltd. Quality 
Manual, Section 05, Appendix 1) is to produce Pharmaceutical and Medical 
Device products according to relevant regulations including current Good 
Manufacturing Practices, the GMP Directive 2003/94/EC and the Council 
Directive 93/42/EEC concerning medical devices. To this end, Rottapharm 
Ltd. has established quality systems and procedures, which ensure that the 
functions, responsibilities and all essential quality criteria associated with the 
manufacture, storage, packing, testing and delivery of all products are 
defined. These systems and procedures are designed to ensure compliance 
with the requirements of regulatory agencies and to meet the needs of our 
customers and product end-users.
The Quality Assurance Department at Rottapharm Ltd. is responsible for 
implementation and monitoring of the QA system, which includes Management 
of the Process Deviation Report (PDR) system.
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1.2 Introduction to the Project
The Rules Governing Medicinal Products in the European Union, Volume 4 
Part 1, Chapter 1, “Quality Management” requires that “any significant 
deviations [from instructions for manufacture; QC sampling, inspection, 
testing, monitoring of environmental conditions and qualitative/quantitative QC  
specifications listed in Marketing Authorisation] are fully recorded and 
investigated”.
Standard Operating Procedure (SOP) QA-SYS-004, ’’The Process Deviation 
Reporting System” details the procedure at Rottapharm Ltd. for recording and 
assessing the impact of deviations from GMP related processes / procedures, 
for implementing immediate corrective actions, and for implementing 
preventative actions to prevent recurrence of the deviation. The scope of this 
SOP is to provide all information relevant to the Process Deviation Report 
(PDR) system at Rottapharm Ltd. for pharmaceutical products, Active 
Pharmaceutical Ingredients (API’s) and Medical Devices.
For the purposes of this project, Process Deviation Reports generated over 
the past 3 years will be examined for Sachet Products where “Human Error” 
has been identified as the primary root cause.
Sachet Products have been chosen for this review as they represent the 
largest output from Rottapharm Ltd. and the process involves significant staff 
commitment, thus it is considered that Human Error PDRs generated during 
Sachet production represents the “worst-case-scenario” for Human Error 
PDRs reported at Rottapharm Ltd. From this review, it is intended that trends 
in deviations will be assessed and the effectiveness of corrective actions 
implemented to reduce frequency of human error deviations can be assessed.
While a product quality review is carried out annually at Rottapharm Ltd. for 
each product, a 3-year "bigger-picture" review such as this will give a broader 
perspective and a more accurate evaluation of how systems & corrective 
actions are impacting on deviation trends over a longer period of time. In
4
addition to corrective and preventative actions already implemented, a review 
of proposed future changes and improvements will also be carried out in this 
thesis.
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2.0 Methodological Details
What is a PDR?
A PDR is a Process Deviation Report. This report is generated when a 
deviation occurs at Rottapharm Ltd. A deviation or non-conformance is defined 
as the non-fulfilment of a specified requirement or an unplanned change from 
a defined process or procedure.
Who is responsible for reporting a PDR?
Any plant personnel who observe a deviation from a process / procedure are 
responsible for highlighting and reporting the deviation according to SOP QA- 
SYS-004. All personnel receive training on this SOP as part of their induction 
and ongoing/refresher training. Typically, an individual observing a deviation 
will highlight the fact to the Area Team Leader, Supervisor or Manager, who 
will complete the initial sections of the PDR form, carry out an initial 
investigation, and report it to the Quality Assurance Department.
Who is involved in the investigation of a PDR?
Once a PDR is received by the Quality Assurance Department, a PDR 
meeting is held to discuss the deviation, potential root causes and propose 
corrective and preventative actions. This discussion involves a multi­
disciplinary approach with attendees from areas involved or affected by the 
deviation and typically includes representatives from Production, Engineering, 
Warehouse, Quality and a Qualified Person.
H on are corrective actions are assigned?
There are two types of actions that are assigned to address a deviation and 
prevent a recurrence of the deviation:
- Type 1 actions are generally critical to determining acceptability of a 
batch or product and must be completed before batch release for
2.1 Overview of the PDR System in Rottapharm Ltd.
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shipment. Examples of Type 1 actions include 100% inspection of the 
affected portion of the batch to assess level of defects; additional 
Quality Control testing; review of data, risk assessment, retraining, etc.
- Type 2 actions are assigned before shipment and may be completed 
after shipment of the batch. These actions are designed to prevent 
recurrence of the deviation. Examples of Type 2 actions include SOP 
update, increase in equipment preventative maintenance frequency, 
retraining etc.
Actions and target dates are agreed and assigned at the PDR meeting. 
Completion of Type 1 and 2 actions within agreed time-frames are monitored 
on an ongoing basis as department metrics. All relevant information, Type 1, 
Type 2 actions, and their associated target completion dates are recorded on 
the PDR form and signature approved. The PDR system at Rottapharm Ltd. is 
paper-based, with a Microsoft Access® Database used to assist tracking of 
completed or outstanding Type 1 or Type 2 actions.
How are PDRs classified?
The severity of all PDRs is assigned by a Qualified Person. A four digit alpha­
numeric code is assigned as outlined below.
The first letter in the code represents the area affected by the PDR:
p = Packaging
M = Manufacturing
E = Engineering
Q = Quality
W = Warehouse
L = Logistics
Z = Plant wide
0 Off site
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A number from the following list indicates the primary root cause of the PDR:
1 = Equipment Failure
2 = Human Error
3 = Material Quality
4 = Unknown
5 = System Error
6 = Utility Failure
7 = Design Limitation
8 = Training
he following list indicates th
S = Material Quality
T = Training
U = Utilities
D = Design Limitations
H = Human Error
N = Unknown
E = Equipment Failure
Finally the severity of the PDR is indicated by a letter from the following list:
M = Minor
S = Serious (Major)
C = Critical
Examples of assigned alpha-numeric PDR codes are presented in the 
appendices.
The severity of the PDR is determined by the following criteria:
Critical: any deviation, which has had, or could potentially have, an
impact on product which could harm a patient.
Major. any deviation, which has had, or could potentially have, an
impact on product, which could cause a customer complaint.
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Recurring Major PDRs may be reclassified as critical at the 
discretion of the Qualified Person.
Minor: any deviation, which has not had a significant product impact but
nevertheless, represents a deviation from an approved process 
or procedure. Recurring minor PDRs may be reclassified as 
Major at the discretion of the Qualified Person.
How are PDRs monitored and trends identified?
(A) Management Review
SOP QA-SYS-006, “The Management Review Process”, requires that 
Management Reviews are carried out on a quarterly basis for Pharmaceutical 
products. Key Performance Indicators are set as company-wide Quality 
Objectives at the start of a calendar year, for example, 2008 KPI for PDRs are:
•  A reduction of 10% in the number of PDRs per million sachets 
produced.
•  Not less than 80% Type 1 Actions completed within agreed timeframe
• Not less than 75% Type 2 Actions completed within agreed timeframe
Performance of the company and individual departments against these targets 
is reviewed and discussed at the quarterly meetings.
(B) Product Quality Review
“The Rules Governing Medicinal Products in the European Union”, Volume 4, 
Part 1, Chapter 1, “Quality Management” states that a Periodic Quality Review 
for a finished product should include “a review of all significant deviations or 
non-conformances, their related investigations, and the effectiveness of 
resultant corrective and preventative actions taken”.
Rottapharm Ltd. SOP QA-SYS-010, “The Annual Product Quality Review” 
(APQR) requires that all aspects relating to the quality of each product 
manufactured at Rottapharm Ltd. is reviewed and reported on an annual 
basis. The APQR report includes an examination of PDRs generated and a 
review of the effectiveness of corrective actions implemented during the year
9
in question.
(1) Quality risk management
“The Rules Governing Medicinal Products in the European Union”, Volume 4, 
Part 1, Chapter 1, “Quality Management” and Annex 20 defines Quality Risk 
Management as a “systematic process for the assessment, control, 
communication and review of risks to the quality of the medicinal product”.
Rottapharm Ltd. SOP QA SYS-061, “Risk Management Policy” is closely 
based on Annex 20 and defines the policy and procedures for risk 
management within Rottapharm Ltd. It is often used in conjunction with the 
implementation of changes, which are managed through the Rottapharm Ltd. 
Change Control System (SOP QA-SYS-009). During the assessment of a 
planned change to a process (including manufacturing process, analytical 
method, facility, product etc.) risk management principles are carefully 
considered to ensure any proposed change does not adversely impact on the 
product manufactured, existing products, or activities that are concurrent in 
GMP facility.
“The Rules Governing Medicinal Products in the European Union”, Volume 4, 
Part 1, Chapter 9, “Self Inspection” requires that “self inspections should be 
conducted in order to monitor the implementation and compliance with Good 
Manufacturing Practice principles and to propose necessary corrective 
measures”. Rottapharm Ltd. SOP QA-SYS-015, “Internal Quality Auditing 
Programme” works to this aim, with all GMP areas and pharmaceutical 
processes audited on a regular basis according to a predefined audit 
schedule.
The PDR system at Rottapharm Ltd. is paper-based, with a Microsoft Access® 
Database “PDR Database” used to assist tracking of PDR approval, 
completed or outstanding actions etc. The database is maintained by the 
Quality Assurance department, who are responsible for inputting all PDR
How are potential PDRs identified and prevented?
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details along with corrective/preventative actions (i.e. Type 1 and 2 actions). 
All company personnel have 'read-only' access to the database, which allows 
staff to track completion of all actions. Department queries have been created 
in the PDR database, which allows any department to obtain ‘live’ lists of 
outstanding actions e.g. the Quality Control query can be used by the Quality 
Control Manager to extract a list of all QC open actions from the PDR 
database. The objective of this 'query' function is to facilitate departments in 
managing on-time closure of their PDR actions.
2.2 Overview of CGS Sachet Manufacturing/Packaging Process
CGS sachet blend sizes are 800 Kg and 2400 Kg. For the 800 Kg sachet 
blend, the raw materials are weighed and sieved through a vibratory sieve 
fitted with a 900pm mesh prior to charging into a 1500 litre Intermediate Bulk 
Container (IBC).
For the 2400 Kg blend, the raw materials are charged into a 3500 litre 
Hosokawa blender located in Process Room M9. In this case, the Crystalline 
Glucosamine Sulphate and the Sorbitol ingredients are dispensed from weight 
controlled bag discharge stations located via a vacuum transfer system to the 
static blender. Remaining excipients are also transferred into the blender 
using the vacuum transfer system.
The sachet mix is blended according to a defined speed and time in a Matcon 
Blender. The IBC containing the sachet blend is then stored until required at 
which point it is transported to the assigned sachet room for filling.
In both cases (i.e. 800Kg or 2400Kg batch size), primary and secondary 
packaging is identical and carried out on either Sachet Line 1 or 2. Primary 
packaging involves the automatic filling of blend into sachets using a 
Marchesini Sachet Filler. Sachets are secondary packaged via the on-line 
insertion of a target number of sachets and information leaflet into a finished 
product carton using a BA Cartoner. Cartons are then automatically packed 
into outer boxes prior to moving to the warehouse, in preparation for shipping.
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Sachet Lines 1 and 2 are fitted with the following modules to carry out in-line 
process checks to assure the quality of the finished product:
- PharmAssist Sachet Checkweigher
- Prisma Carton Checkweigher
- Pharmacode Monitoring System for leaflets and cartons
- Metler-Toledo X-Ray Inspection Units.
The process flow of the CGS Sachet manufacturing and packaging process is 
outlined below. The process flow for Plantaben Sachets is essentially similar 
with different materials, blending conditions and target weights applied.
CGS Sachet manufacturing and packaging process:
Blending according to a defined speed and time
Dispensing/Sieving of Active and Excipients Materials 
(CGS, Citric Acid, PEG 4000, Aspartame & Sorbitol)
Primary Packaging
filling of sachet blend into single foil 
sachets (3.95g target)
1
Secondary Packaging
Packaging of a target number of sachets and leaflet into
cartons
I
Packaging of cartons in outer boxes => pallets
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2.3 Methods used to analyse the data
For this project, data from the Microsoft Access® PDR database for the years 
under examination were exported into a Microsoft Excel® Spreadsheet where 
it was manipulated to provide the necessary comparisons with respect to 
product and primary root cause, i.e. Sachets and Human Error.
This above information, in conjunction with the QA Summary Report and QP 
Final Report, were utilised to identify the corrective and preventative actions 
implemented at the time of the PDR investigation. The QA Summary Report is 
prepared by a member of the Quality Assurance department when all Type 1 
actions have been completed and when Type 2 actions have been agreed. 
This Summary Report includes a complete review of the primary root cause of 
PDR, what Type 1 (corrective) actions were applied to address the deviation 
prior to batch release, and what Type 2 actions have been agreed which will 
prevent recurrence of the PDR. This report is reviewed by the Qualified 
Person prior to making their batch disposition decision. Once the Type 2 
actions are completed, the Qualified Person completes the QP Final Report 
section of the PDR Form. This report includes an assessment of the Type 2 
(preventative) actions applied, and the rationale for their batch disposition 
decision.
A review of all Sachet Human Error PDRs for 2006 to 2008 was also carried 
out to identify potential reoccurrence of the same issues and thus assess the 
effectiveness of the original corrective actions implemented.
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3.0 Results
Appendices I, II and III summarise the details, severity and primary and secondary 
root cause of Sachet PDRs reported in 2006, 2007 and 2008. The data in these 
appendices was analysed to quantify data by product type, by severity and by 
primary root cause (Human Error), to evaluate the corrective actions assigned to 
address the primary root cause. This data is presented in Sections 3.1, 3.2, 3.3 and 
3.4.
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3.1 2006 PDRs
Table 3.1
Table 3.1 and Chart 3.1 demonstrate the breakdown of the total PDRs reported by
primary root cause. It is evident that the highest occurrence is for Equipment Failure
and Human Error.
P rim a r y  R o o t  
C a u s e
%
E q u ip m e n t
F a ilu re
56 35
H u m a n  E r r o r 5 2 33
M a te rial
Q u a lity
1 6 10
U n k n o w n 2 5 16
S y s te m  E rr o r 5 3
Utility Fa ilu re 2 1
D e s ig n
Lim ita tio n
2 1
T ra in in g 1 1
Total 159
Chart 3.1
2006 Primary Root Cause
■ Equipment Failure 
a  Human Error 
a  M aterial Quality 
a  Unknown 
b  System Error 
b  U tility  Failure 
□ Design Limitation 
e  Training
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Table 3.2 and Chart 3.2 demonstrate the breakdown of the total 2006 PDRs reported 
by severity. A significant number of PDRs (75%) were for unsealed or badly cut 
sachets and were classified as Major due to their recurring nature and the potential 
for a customer complaint to be reported, had the defect not been detected. The 
majority of other PDRs were classified as minor in nature.
Table 3.2
S e v e r i t y # %
M in o r 7 9 50
S e rio u s
(M a jo r)
7 6 * 4 8
Critical 4 3
Chart 3.2
2006 PDR Severity
■ M inor
■ Serious (M ^ o r )
■ Critical
Table 3.3 and 3.4 demonstrate the quantity and severity of 2006 Sachet PDRs 
caused by Human Error.
Table 3.3
T o ta l n o . P D R s 1 5 9
N o . S a c h e t P D R s 59
N o . S a c h e t P D R s  
c a u s e d  b y  H u m a n  E r r o r 1 5
%  o f s a c h e t P D R s  
c a u s e d  b y H u m a n  E r r o r 2 5
Table 3.4
S e v e r i ty #  H u m a n  e r r o r s
%  H u m a n  
e r r o r s
M in o r 7 1 4
M a jo r 8 1 6
Critical 0 0
Table 3.5 demonstrates the types of corrective actions that were applied to 2006 
Human Error Sachet PDRs.
Table 3.5
T y p e s  o f  C o r r e c t iv e  A c ti o n s  a p p l ie d . #  i n s t a n c e s
R e tra in in g 1 4
D o c u m e n ta tio n  U p d a te .
E .g .  trainin g m a n u a l, S O P ,  B a tc h  R e c o r d s 8
O t h e r ?  E .g .  H R  in v o lv e m e n t, disc ip lin a ry 
p ro c e e d in g s 1
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3.2 2007 PDRs
Table 3.6
Table 3.6 and Chart 3.3 demonstrate the breakdown of the total PDRs reported by
primary root cause. It is evident that the highest occurrence is for Equipment Failure,
Human Error and Unknown.
P rim a ry  R o o t  
C a u s e %
E q u ip m e n t
F a ilu re 6 1 33
H u m a n
E r r o r 5 7 30
M a te rial
Q u a lity 6 3
U n k n o w n 4 9 26
S y s te m
E r r o r 2 1
Utility
Fa ilu re 0 0
D e s ig n
Lim itatio n 1 0 5
Tra in in g 2 1
Total 187
Chart 3.3
2007 Primary Root Cause
■ Equipment Failure
■ Human Error
■ M aterial Quality
■  Unknown
■ System Error
■ U tility  Failure
□ Design Limitation 
ei Training
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Table 3.7 and Chart 3.4 demonstrate the breakdown of the total 2007 PDRs reported 
by severity. A significant number of PDRs (85%) were for unsealed or badly cut 
sachets and were classified as Major due to their recurring nature and the potential 
for a customer complaint to be reported, had the defect not been detected. The 
majority of other PDRs were classified as minor in nature.
Table 3.7
S e v e r ity # %
M in o r 6 7 36
S e r io u s
(M a jo r) 1 2 0 64
Critical 0 0
Chart 3.4 
2007 PDR Severity
Table 3.8 and 3.9 demonstrate the quantity and severity of 2007 Sachet PDRs 
caused by Human Error.
Table 3.8
T o ta l n o . P D R s 1 8 7
N o . S a c h e t P D R s 93
N o . S a c h e t P D R s  c a u s e d  
b y H u m a n  E r r o r 1 8
%  o f  s a c h e t P D R s  c a u s e d  
b y H u m a n  E r r o r 1 9
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Table 3.9
S e v e r i ty #  H u m a n  e r r o r s
%  H u m a n  
e r r o r s
M in o r 5 1 0
M a jo r 1 3 2 6
Critical 0 0
Table 3.10 demonstrates the types of corrective actions that were applied to 2007 
Human Error Sachet PDRs.
Table 3.10
T y p e s  o f  C o r r e c t iv e  A c tio n s  a p p l ie d . #  i n s t a n c e s
R e tra in in g 1 6
D o c u m e n ta tio n  U p d a te .
E .g .  train ing m a n u a l, S O P ,  B a tc h  R e c o r d s 6
O t h e r ?  E .g .  H R  in v o lv e m e n t, d iscip lin ary 
p ro c e e d in g s 0
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3.3 2008 PDRs
Table 3.11
Table 3.11 and Chart 3.5 demonstrate the breakdown of the total PDRs reported by
primary root cause. It Is evident that the highest occurrence is for Equipment Failure,
Human Error and Unknown.
P rim a ry  R o o t  
C a u s e %
E q u ip m e n t
F a ilu re 7 4 45
H u m a n
E rr o r 6 2 38
M a te rial
Q u a lity 3 2
U n k n o w n 2 0 12
S y s te m
E r r o r 2 1
Utility
F a ilu re 0 0
D e s ig n
Lim itatio n 2 1
Tra in in g 0 0
Total 163
Chart 3.5
2008 Primary Root Cause
■ Equipment Failure
■ Human Error
■ M aterial Quality
■ Unknown
■ System Error 
a  Utility Failure
□ Design Limitation
□ Training
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Table 3.12 and Chart 3.6 demonstrate the breakdown of the total 2008 PDRs 
reported by severity. A significant number of PDRs (61%) were for unsealed or badly 
cut sachets and were classified as Major due to their recurring nature and the 
potential for a customer complaint to be reported, had the defect not been detected. 
The majority of other PDRs were classified as minor in nature.
Table 3.12
S e v e r i ty # %
M in o r 8 9 5 5
S e rio u s
(M a jo r) 7 4 * 4 5
Critical 0 0
Chart 3.6 
2008 PDR Severity
i M inor
i Serious (M ajo r) 
i Critical
Table 3.13 and 3.14 demonstrate the quantity and severity of 2008 Sachet PDRs 
caused by Human Error.
Table 3.13
T o ta l n o . P D R s 1 6 3
N o . S a c h e t P D R s 7 7
N o . S a c h e t  P D R s  
c a u s e d  b y H u m a n  
E r r o r 2 6
%  o f s a c h e t P D R s  
c a u s e d  b y  H u m a n  
E r r o r 34
22
Table 3.14
S e v e r i ty #  H u m a n  e r r o r s
%  H u m a n  
e r r o r s
M in o r 1 7 65
M a jo r 9 35
Critical 0 0
Table 3.15 demonstrates the types of corrective actions that were applied to 2007 
Human Error Sachet PDRs.
Table 3.15
T y p e s  o f  C o r r e c t iv e  A c t io n s  a p p l ie d . #  i n s t a n c e s
R e tra in in g 23
D o c u m e n ta tio n  U p d a te .
E .g .  train ing m a n u a l, S O P ,  B a tc h  R e c o r d s 6
O t h e r ?  E .g .  H R  in v o lv e m e n t, disc ip lin a ry 
p ro c e e d in g s 1
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3.4 Comparison of 2006, 2007 and 2008 PDR Data
Table 3.16 compares the total number of PDRs per million sachets reported per year.
Table 3.16
Y e a r
T o ta l  #  P D R s 
r e p o r te d
# M illio n  
S a c h e t s  
P r o d u c e d
T o ta l  # P D R s  
p e r  m illio n  
s a c h e t s
%  c h a n g e  o n  
p r e v io u s  y e a r
2 0 0 6 15 9 1 6 4 0 .9 7 0 N / A
2 0 0 7 1 8 7 1 8 5 1 .0 1 1 + 4 %
2 0 0 8 16 3 1 9 6 0 .8 3 2 - 1 8 %
Table 3.17 compares the total number of Sachet PDRs per million sachets reported 
per year.
Table 3.17
Y e a r
#  S a c h e t  
P D R s
#  M illion  
S a c h e t s  
P r o d u c e d
#  S a c h e t  
P D R s  p e r  
m illio n  
s a c h e t s
%  c h a n g e  o n  
p r e v i o u s  y e a r
2 0 0 6 59 1 6 4 0 .3 5 9 N / A
2 0 0 7 93 1 8 5 0 .5 0 2 + 4 0 %
2 0 0 8 7 7 1 9 6 0 .3 9 3 - 2 2 %
Table 3.18 and Chart 3.7 compare the types and instances of corrective actions 
implemented for Sachet Human Error PDRs per year.
Table 3.18
# i n s t a n c e s
T y p e s  o f  C o r r e c t iv e  A c tio n s  
a p p l ie d . 2 0 0 6 2 0 0 7 2 0 0 8
R e tra in in g 1 4 1 6 2 3
D o c u m e n ta tio n  U p d a te 8 6 6
O t h e r 1 0 1
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Chart 3.7
Types of Corrective Actions applied to Sachet Human Errors
2006 2007 2008
Y e a r
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4.0 Discussion
The largest root cause of PDRs in 2006 was Equipment Failure (35%), 
followed by Human Error (33%) (Table 3.1). When examining Sachet PDRs 
specifically, it is observed that 25% (15 out of 59 Sachet PDRs) were caused 
by Human Error (Table 3.3). These Sachet Human Error PDRs and their 
respective corrective actions were reviewed in accordance with 2007 and 
2008 PDRs to assess the effectiveness of actions implemented to prevent 
reoccurrence of the issue.
In 2006, three Sachet PDRs were caused by deficiencies in the Engineering 
Training Manuals. In one instance (PDR-06-004-S), over adjustment of 
equipment parameters during an engineering intervention caused badly cut 
sachets to occur. In the second instance (PDR-06-161-S), a screw removed 
during equipment maintenance was found in a carton of sachets. PDR-06-097- 
S also reported a screw found in a carton for the same reason. These specific 
PDRs were addressed by an update to Engineering Training Manuals, which 
all Technicians were subsequently trained on. These specific issues did not 
reoccur during the rest of 2006 or throughout 2007, confirming the 
effectiveness of the action taken. The Engineering Training Manuals required 
further update in 2007 as result of two PDRs; to include a requirement to 
advise Production Operators prior to the power-down of equipment in-use, and 
to include a requirement that while necessary engineering maintenance work 
is on-going, any and all product produced during that time must be rejected. 
The updates to the Engineering Training Manuals carried out in 2006 and 
2007 are considered to be effective as PDRs have not reoccurred for the 
same reasons, with two exceptions in 2008: (A) PDR-08-132-S and (B) PDR- 
08-028-S, which resulted (A) in an incorrect expiry date being applied to 
cartons caused by Engineering Technicians not advising Production that 
printer was powered down and (B) a screw removed during maintenance work 
was found in a carton caused by an Engineer not reconciling screws following
4.1 Sachet Human Error PDRs
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maintenance work. Both of these issues had been included in Engineering 
Training Manuals in 2006 and 2007, and the specific Technicians were 
retrained in 2008. No further reports of these types of PDRs arose in the latter 
part of 2008, but this will require to be further monitored to assure the 
continued effectiveness of the Engineering Training Manuals and the 
retraining provided in 2008.
Due to the number of PDRs reported relating to incorrect material check-in in 
late 2005, a ‘Material Check-in Training Module’ was introduced to ensure 
production, warehouse and quality personnel received specific training in this 
subject. The effectiveness of this training was demonstrated by the fact that no 
Sachet deviations were reported relating to material check-in during 2006 and 
2007 (Appendix I and II). One Sachet PDR was reported in 2008 due to 
Human Error during material check-in (PDR-08-086-S). The root cause was 
attributed to staff turnover since initial training on the original 'Material Check­
in Training Module’, and that all new staff employed since 2006 had not 
completed the training module. Corrective action to address this was to 
complete Material Check-in training with all personnel who had not received 
the original training. In addition, training on Material Check-in is now to be 
delivered to all new employees in these areas. This had not previously been 
monitored to ensure new staff completed this training module as part of their 
standard induction and job/task training, but it has since been initiated by the 
Training Coordinator. SOP PRO-GEN-025, “Task Training Procedure for 
Production Personnel at Rottapharm Ltd." details production and warehouse 
department specific training requirements. The current procedure requires that 
a controlled Task Training Manual’ which details the training requirements for 
a specific “task” is issued to a trainee by the Training Coordinator.
SOP PRO-GEN-025 contains a list of approved Task Training Manuals and 
was last updated in March 2008, but it does not refer to the ‘Material Check-in 
Training Module’. While the corrective action resulting from PDR-08-086-S will 
ensure in the short term that the issue does not reoccur, it does not provide for 
a longer-term prevention and if not proceduralised, there is a risk that the 
issue could reoccur. It is recommended that SOP PRO-GEN-025 be updated
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to include the ‘Material Check-in Training Module’ to address this.
The highest root cause of PDRs in 2007 was Equipment Failure (33%), 
followed by Human Error (30%) and Unknown (26%), where the exact root 
cause was not evident (Table 3.6). When examining Sachet PDRs specifically, 
it is observed that 19% (18 out of 93 Sachet PDRs) were caused by Human 
Error in 2007 (Table 3.8).
While the total number of PDRs reported in 2007 (185 PDRs) appears to have 
increased in direct comparison with 2006 (159 PDRs), this does not take into 
account of the increase in output volumes (Table 3.16). To normalise the 
annual figures and compare ‘like-with-like’, output volumes must be taken into 
consideration to give a more accurate reflection of the performance per year in 
terms of PDRs. When comparing the total number of PDRs to Sachet output, a 
4% increase in the total number of PDRs per million sachets between 2006 
and 2007 is observed (Table 3.16). The minor increase was reversed in 2008, 
with the number of PDRs per million sachets decreasing by 18% compared to 
2007. Overall, the performance in terms of PDRs has improved over the three 
year period with a decrease from 0.970 PDRs per million sachets in 2006 to 
0.832 PDRs per million sachets in 2008 (Table 3.16).
Speed increases and improved efficiencies on the Sachet Lines during 2007 
and 2008 contributed to the overall reduction in PDRs per million sachets, the 
most significant being the completion of a six-sigma project into unsealed and 
badly cut sachets. Problems with these defects had previously resulted in a 
significant number of PDRs, with Equipment Error and Unknown the primary 
root causes assigned. This project commenced in late 2006 and continued 
throughout 2007. The objective of the 2006/2007 six-sigma project was to 
identify possible causes and implement actions to reduce occurrences of 
unsealed and badly cut sachets to improve product quality and improve 
efficiency of the line by reducing rework and 100% inspections. The main 
recommendations from the project included (among others) increased 
frequency of preventative maintenance of the sachet fillers, and improved
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cleaning of Intermediate Bulk Containers (IBCs); more specifically improved 
drying of these containers; as it was found that moisture can cause lumps in 
blends which can cause problems during filling and contribute to unsealed 
sachets. The numbers of instances of unsealed/badly cut sachet defects 
observed during inspections were trended in 2007 to assess and monitor the 
performance of the process. In the Rottapharm Ltd. 2007 Annual Product 
Quality Review report for CGS Sachets, results were presented that showed a 
decrease in the number of instances of these defect types throughout 2007 to 
below the six-sigma defect level. The number of defects per inspection will 
continue to be monitored to ensure the process continues to achieve the six- 
sigma defect level.
Incorrect or missing variable data on cartons was an issue during 2007; with 6 
out of 18 Human Error Sachet PDRs being reported for this issue (PDR-07- 
004-S, PDR-07-041-S, PDR-07-058-S, PDR-07-068-S, PDR-07-071-S, and 
PDR-07-103-S). Missing variable data was addressed by retraining in two 
instances and an update to Engineering Training Manual in one to ensure 
Production Operators are immediately notified of any power-down of 
equipment during production. Incorrect variable data (e.g. incorrect price or 
expiry date) was determined to be caused by poor or absent second checks 
and resulted in retraining for personnel involved. The corrective actions 
implemented were effective in reducing this type of PDR with only one 
occurrence reported in 2008 (PDR-08-026-S) whereby an incorrect date of 
manufacture was recorded on cartons. This was again addressed by retraining 
and the issue has not reoccurred since. While individual retraining sessions 
appear to be effective, it is recommended that department-wide and inter­
department communication of PDR root causes be introduced on an ongoing 
basis to increase awareness and vigilance of such issues.
While two other instances of incorrect variable data were reported in 2008, 
these were treated separately as they had unique root causes unrelated to 
those previously observed. PDR-08-132-S was discussed previously and was 
caused by Engineering not advising Production that printer was powered 
down. PDR-08-126-S was reported as an incorrect batch number was
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assigned as XXA on issued batch documentation, where it should have been 
XXB. The root cause was identified as be Human Error and was attributed to 
a combination of inexperience and a lack of training, as the specific product 
presentation was not routine and the ‘back-up’ Document Controller had not 
encountered it to this point. The error was highlighted by production in 
advance and was corrected before any product was packaged, thus there was 
no product impact. The ‘back-up’ Document Controller was subsequently 
trained on this specific product presentation.
In July 2007, two instances of contaminated Sachet Blend were reported with 
a root cause of Human Error. PDR-07-116-S and PDR-07-123-S reported 
contamination of Sachet Blend with blue nitrile glove and nylon cable, 
respectively. Disposable gloves were removed from the area and the API bulk 
production SOP’s were updated to detail use and cleaning of heavy duty 
gloves. All API bulk operators received training on the new SOP and on 
general contamination minimisation procedures. This corrective action was 
effective as this type of PDR has not reoccurred to date.
The largest root cause of PDRs in 2008 was Equipment Failure (45%), 
followed by Human Error (38%) (Table 3.11). When examining Sachet PDRs 
specifically, it is observed that 34% (26 out of 77 Sachet PDRs) were caused 
by Human Error in 2008 (Table 3.13).
There were two significant events that impacted the Sachet Line in 2008.
(A) 2008 saw the introduction of a new product (Plantaben) to the Sachet 
Lines. Prior to this, the Sachet Lines were dedicated to one product -  
Crystalline Glucosamine Sulphate. This project involved the introduction 
of new materials, cleaning procedures, batch files and other general 
procedures to the Area. Trials were carried out in May, validation of the 
process took place in August, and the product went into routine 
production in November. Training and other requirements were 
managed through the change control system.
(B) November 2008 also saw the introduction of a third (night) shift for the
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sachet packaging lines. This meant that equipment was running for 
50% longer per working day and a number of newly recruited personnel 
were introduced into engineering, production, warehouse and quality 
roles.
The extra workload for equipment was assessed with respect to 
preventative maintenance and parts replacement to ensure process 
efficiency and product quality were not compromised. New preventative 
maintenance and equipment/area cleaning schedules were put in place.
To allow for the fact that night shift staff would not have the same 
support network as day/evening shift staff do, in terms of numbers of 
other staff and management on-site, existing experienced employees 
from engineering, warehouse, production and quality were moved to the 
night shift. While some of their positions were back-filled by existing 
employees, some were filled with new recruits. During day/evening 
shifts there is more staff on-site, which affords the required training and 
supervision needed for new staff.
2008 PDRs other than those already discussed were reviewed. They were 
addressed by retraining and/or document updates, e.g. SOP, batch record, 
etc. and were considered to be isolated issues and not constituting an adverse 
trend.
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4.2 Current procedures for managing Human Error PDRs at 
Rottapharm Ltd.
4.2.1 Training as a Preventative Action (Initial Training, Refresher 
Training, and prior to Implementing a Change)
The Rules Governing Medicinal Products in the European Union, 
Volume 4 Part 1, Chapter 2, “Personnel” requires that “all personnel 
should be aware of the principles of Good Manufacturing Practice 
(GMP) that affect them and receive initial and continuing training, 
including hygiene instructions, relevant to their needs”.
To meet this requirement, initial and refresher GMP training is provided 
to all employees on an ongoing basis, and is outlined in SOP FAC- 
GEN-001, “General Training Procedure”. New recruits receive GMP 
training as part of induction. All employees receive refresher GMP 
training on an annual basis. At Rottapharm Ltd. the refresher GMP 
training programme includes a section on the PDR system with some 
'real' examples that personnel can easily identify with, to remind them to 
ensure that any departures from approved procedures are reported if 
observed. While this is a requirement of the quality system, it was 
noted during research for this project that it is currently not defined 
where the responsibility lies for managing the refresher GMP training 
programme, i.e. if it is
•  Quality Assurance (who are responsible for delivering the 
training);
•  Human Resources (who have responsibility for administering 
training system); or
•  Individual department managers (who are responsible for 
ensuring their employees are fully trained)?
As responsibility for the management of the facility refresher GMP
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training programme is not currently defined, there is a risk that not all 
personnel will receive refresher training in compliance with SOP FAC- 
GEN-001. To address this 'gap' in the system, it is recommended that 
SOP FAC-GEN-001, “The Training Procedure at Rottapharm Ltd.” be 
updated to incorporate the following:
•  Definition of the persons/department responsible for managing the 
refresher GMP training programme.
•  A schedule for routine refresher GMP training that can be tracked 
and progress monitored at the quarterly Management Reviews.
In addition to initial and refresher training, training delivered following 
new process/product/equipment introduction or a change to existing 
process/product/equipment is also carried out. Training requirements 
are evaluated using the principles of quality risk management during the 
change control process and managed via change control system, 
whereby responsible persons and target completion dates are agreed, 
and documented evidence of completion must be presented to change 
controller prior to closure of the “action” and approval by a Qualified 
Person to proceed with the proposed change.
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4.2.2 Training as a Corrective Action (Retraining as corrective 
action following a PDR)
Retraining can be a short-term corrective action and does not always 
prevent reoccurrence of a PDR. While individual retraining sessions 
appear to be effective in the short-term, it is recommended that 
department-wide and inter-department communication of PDR root 
causes be introduced to increase awareness and vigilance of such 
issues on a routine basis. Improved awareness and involvement from 
personnel at all levels/positions is necessary in ensuring employees 
remain vigilant to prevent potential Human Error PDRs.
Human error as a root cause of deviations cannot completely be 
eliminated while humans are involved in processes, but they can be 
controlled and minimised. Planned future changes to limit and control 
Human involvement with processes should see a reduction in PDRs 
caused by Human Error.
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4.3 Industry Benchmarking
A cross-section of approaches from industry to managing Human Error 
PDRs was reviewed.
Table 4.1
Company Business Number of Employees
Company A A specialty pharmaceutical 
development company
<100 employees
Company B A leading manufacturer of solid 
oral and parenteral medicines
100 - 500 employees
Company C A multinational biopharmaceutical 
company
>1,000 employees
Rottapharm Ltd. Solid oral dosage manufacturer -150 employees
Approach of Company A and Company C:
If a PDR or error is reported, a root cause must be identified. A root 
cause of “Human Error” may result in retraining of the individual(s) or 
document update e.g. SOP, checklist, batch record, etc.
In addition, in Company C the individual is 'counseled' by the Area 
Manager, i.e. they are made aware of the exact error, the investigation 
and the correct way they should have proceeded. Also, the individual is 
involved in writing up the investigation and conclusion to ensure a full 
understanding of the issue. Area Managers also carry out 
communications with the different shifts to emphasis human error trends 
so that it's not just one particular individual getting the benefit of the 
counseling but the entire team.
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In Company B, "Human Error” is not an optional root cause for a PDR, 
and retraining is not optional corrective action. Examples of 
classification of “Human Errors” in Company C include “Application 
Errors”, “Omission Errors”, “Learning Gaps”, etc. The specific root 
cause for the PDR must be identified and corrective action should 
incorporate a change to a process, document or SOP to improve or 
clarify the process; the process is considered deficient is a person can 
make an error. Once the process deficiency is addressed, personnel 
are trained on the new process. The aim of this system is to move away 
from ineffective retraining or token procedure updates and put ‘physical 
barriers’ in place to make it impossible for personnel to make the same 
mistake twice, i.e. ‘mistake proofing’. For example, a PDR is reported 
due to a mix-up between two similar looking reagents in a press. The 
corrective action may be to move one of them to a different location, or 
label with different colour labels to make them physically different.
The approach in Rottapharm Ltd. is similar to that of Companies A and 
C. With previous recommendations from this project including increased 
communication with different departments to highlight Human Error 
trends, awareness and vigilance to these issues will be further 
improved.
It is also recommended that the process of assigning the root cause of a 
PDR is reviewed, to ensure that “Human Error” is not being assigned as 
a ‘catch-all’ root cause and that the true root cause of a PDR is 
identified. To support this, external training on Root Cause Investigation 
has been planned for completion in 2009 for employees involved in 
investigating PDRs. When reviewing the PDR investigation process with 
respect to correct root cause identification, the approach of ‘mistake 
proofing’ as a corrective action, will be reviewed by Rottapharm Ltd. for 
potential implementation.
Approach of Company B:
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4.4 Planned future changes & improvements
A Manufacturing Execution System (MES) with electronic batch records 
is planned to be implemented in Rottapharm Ltd. with the following 
capabilities:
- Current labelling system to be replaced with a barcode scanning 
system to prevent incorrect material picked by warehouse and/or 
dispensed by production -  the Warehouse module is planned for 
implementation in June 2009, with the Production module to follow 
by 2010.
- Paper-less (or much reduced) system with hand-held notebook 
computers (Electronic Batch Records replacing paper Batch 
Records)
- Removing or at least reducing Human/Equipment interfaces with 
process equipment
-  Cannot proceed to next stage of processing if there is a step 
incomplete or incorrectly completed
-  Pass/fail options for in-process checks, and cannot proceed if fail
-  Secure operator/approver options
- QA batch file review will be 'review by exception1 -  greatly simplified 
& reduction in review times for Quality Assurance and Qualified 
Person.
Development of new technologies such as Process Analytical 
Technology (PAT) for use in Pharmaceutical industry also opens 
opportunities for companies to improve the quality of their product and 
thus reduce errors, batch reject/rework and production down-time to 
mention a few benefits. These benefits reduce labour costs and 
improve batch turnaround times, which reduce product costs and in-turn 
improve company cost effectiveness in an increasingly more 
competitive market.
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Process Analytical Technology is defined by the US FDA as “a system 
for designing, analyzing, and controlling manufacturing through timely 
measurements (i.e., during processing) of critical quality and 
performance attributes of raw and in-process materials and processes 
with the goal of ensuring final product quality”.
The US FDA have identified that the desired goal of the PAT framework 
is to design and develop processes that can consistently ensure a 
predefined quality at the end of the manufacturing process. Such 
procedures would be consistent with the basic tenet of quality by design 
and could reduce risks to quality and regulatory concerns while 
improving efficiency. Gains in quality, safety and/or efficiency will vary 
depending on the product and are likely to come from:
. Reducing production cycle times by using on-, in-, and/or at-line 
measurements and controls.
. Preventing rejects, scrap, and re-processing.
. Considering the possibility of real time release, 
t Increasing automation to improve operator safety and reduce 
human error.
• Facilitating continuous processing to improve efficiency and 
manage variability
• Using small-scale equipment (to eliminate certain scale-up 
issues) and dedicated manufacturing facilities.
. Improving energy and material use and increasing capacity.
The potential uses for PAT in Rottapharm Ltd. include the following:
- Confirm correct materials being used, reaction/blending completed 
e.g. Sachet Blending
-  Remove need for Production to take samples for off-line analysis 
e.g. API Manufacture
It is evident from the potential gains of PAT outlined above, that a 
reduction in the number of deviations caused by human error would be
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closely linked to an overall improvement in product quality and 
efficiency.
5.0 Summary and Conclusions
Retraining is a common corrective or preventative action to a PDR in Rottapharm 
Ltd. and in other similar pharmaceutical companies. While retraining sessions 
appear to be effective in the short-term, further medium- and long-term solutions 
must be found to address Human Error PDRs. Electronic process management 
systems (e.g. MES) and in-line testing can control and monitor processes, but for the 
foreseeable future, people will still control these systems.
Techniques to reduce levels of Human Error PDRs include ‘mistake proofing’, 
improvement of training manuals and department-wide and inter-department 
communication of PDR root causes to increase awareness and vigilance of issues. In 
addition, procedures, checklists and in-process checks can be implemented to train 
and guide personnel, and their performance can be monitored by second check 
reviews. These and other techniques can minimise Human Error PDRs, but they 
cannot eliminate them completely. When people are involved, the potential for 
Human Error PDRs to occur is a very real one that cannot be eliminated.
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APPENDIX I
Appendix I
P D R  N u m b e r O r i g i n a t i n g
D e p a r t m e n t
Product
T y p e
Brief Description C a t e g o r y C l a s s i fi c a t i o n P r i m a r y  R o o t  
C a u s e
P D R -06-001-S Production Sachets Unsealed Sachet Minor P17M Equipment
Failure
P D R -06-004-S Production Sachets Badly Cut Sachets Minor P2TM Human error
P D R -06-005-S Production Sachets Unsealed sachets Major P1DS Equipment
Failure
P D R -06-009-S Production Sachets Unsealed Sachets M ajor P1DM Equipment
Failure
P D R -06-012-S Production Sachets Unsealed Sachets Major P4NS Unknown
P D R -06-013-S Production Sachets Unsealed Sachets Minor P1NM Equipment
Failure
P D R -06-014 -G Logistics Sachets Q A removed from Engineering 
Change O rder (E C O ) as an 
Approver
Major L2DS Human error
P D R -06-018-S Production Sachets Unsealed Sachets Major P1ES Equipment
Failure
P D R -06 -022 -S Production Sachets Unsealed sachets / Lumps in blend Major M 4N S Unknown
P D R -06-025-S Production Sachets Unsealed Sachets Major P1DS Equipment
Failure
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P D R  N u m b e r O r i g i n a t i n g
D e p a r t m e n t
P r o d u c t
T y p e
B r i e f  D e s c r ip t i o n C a t e g o r y C l a s s i f i c a t i o n P r i m a r y  R o o t  
C a u s e
P D R -06-026-S Production Sachets Unsealed Sachets Minor P1DM Equipment
Failure
P D R -06-038-S Production Sachets The agitator rod on the dosator on 
sachet filler S F102 seized and 
stopped
Major P1D S Equipment
Failure
P D R -06-040-S Production Sachets Defective lot of Foil Major P1NS Equipment
Failure
P D R -06-043-S Production Sachets Unsealed Sachets Major P1DS Equipment
Failure
P D R -06-046-S Production Sachets Badly Cut unsealed sachets Minor P1NM Equipment
Failure
P D R -06-047-S Production Sachets Unsealed sachet Major P3ES Material Quality
P D R -06-051-S Production Sachets Badly cut sachet from SF102 Major P3ES Material Quality
P D R -06-054-S Production Sachets Unsealed badly cut sachets Major P IT S Equipment
Failure
P D R -06-056-S Production Sachets Incorrect batch number on Sachets 
from filler, S F102
Major P2HS Fluman error
P D R -06-057-S Quality
Assurance
Sachets Duplication of batch numbers for 
secondary packaging of sub­
batches
Major P2HS Human error
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P D R  N u m b e r O r ig i n a t i n g
D e p a r t m e n t
P r o d u c t
T y p e
B r ie f  D e s c r ip t i o n C a t e g o r y C l a s s i f i c a t i o n P r i m a r y  R o o t  
C a u s e
P D R -06-058-S Production Sachets Badly Sealed Sachet Minor P4N M Unknown
P D R -06-060-S Production Sachets Unsealed sachets Major P2HS Human error
P D R -06-061-S Production Sachets Badly Sealed Sachets Major P1NS Equipment
Failure
P D R -06 -062 -S Production Sachets Dam aged twin sachet and incorrect 
quantity of sachets in carton
Major P1NS Equipment
Failure
P D R -06-067-S Quality Control Sachets W eight issues with C G S  Sachet 
Batch Z-60
Major P4NS Unknown
P D R -06-069-S Quality
Assurance
Sachets BPR missing for batch Major Q 2H S Human error
P D R -06-071-S Production Sachets Expiry date changed due to power 
down of machine
Major P2DS Human error
P D R -06-074-S Production Sachets Unsealed Sachets found in P2 Minor PINM Equipment
Failure
P D R -06-081-S Production Sachets Seal test failures Major P3ES Material Quality
P D R -06-083-S Production Sachets Unsealed and badly cut sachets Major P3DS Material Quality
P D R -06-087-S Production Sachets Unsealed Sachets Minor P3NM Material Quality
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P D R  N u m b e r O r ig i n a t i n g
D e p a r t m e n t
P r o d u c t
T y p e
B r ie f  D e s c r ip t i o n C a t e g o r y C l a s s i f i c a t i o n P r i m a r y  R o o t  
C a u s e
P D R -06-090-S Production Sachets Unsealed sachet found during Bulk 
Packaging
Major P1SS Equipment
Failure
P D R -06-095-S Quality Control Sachets W eight Control Issues for sachet 
filler S F 1 02
Major P 1HS Equipment
Failure
P D R -06-097-S Production Sachets Screw found in carton at 
checkweigher reject station
Minor P2HM Fluman error
P D R -06-098-S Production Sachets Unsealed sachet found in P1 Minor P1HM Equipment
Failure
P D R -06-106-S Production Sachets Badly Cut Sachet found in P1 Minor P1ES Equipment
Failure
P D R -06-109-S Production Sachets Badly sealed sachet from SF101 Major P1HS Equipment
Failure
P D R -06-116-B Production Sachets W rong ‘data de frabricaccao’ on 
drum label
Minor P5TM System Error
P D R -06-117-S Production Sachets Total batch weight following 
Dispensing O O S
Minor M 2HM Fluman error
P D R -06-118-S Production Sachets Badly Cut Sachets found at 
checkweigher
Major P1HS Equipment
Failure
P D R -06-119-S Production Sachets Unsealed Sachets found in P1 Major P1ES Equipment
Failure
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P D R  N u m b e r O r i g i n a t i n g
D e p a r t m e n t
P r o d u c t
T y p e
B r ie f  D e s c r ip t i o n Category Classification Primary Root 
C a u s e
P D R -06-121-S Production Sachets Unsealed Sachet found in P1 Major P4NS Unknown
P D R -06-123-S Production Sachets Unsealed sachets due to lumps in 
blend
Major P4NS Unknown
PD R -06-126-S Production Sachets Incorrect Blending for sachet 
blends
Minor M 2H M Human error
P D R -06-128-S Production Sachets Unsealed Sachet in P2 from SF103 Major P2TS Human error
P D R -06-129-S Quality Control Sachets W eight issues with batch Major P1ES Equipment
Failure
P D R -06-132-S Technical
Services
Sachets The blender BL-102 screw would 
not rotate when blending was 
started
Minor M 1EM Equipment
Failure
P D R -06-134-S Production Sachets Unsealed Sachet found in P1 Major P4ES Unknown
P D R -06-136-S Production Sachets Badly Cut sachet found in P1 Major P4ES Unknown
P D R -06-137-S Quality Control Sachets Unsealed Sachet found in Q C  Lab Major P3ES Material Quality
P D R -06-144-S Production Sachets Badly Cut sachet found in P2 Major P1ES Equipment
Failure
P D R -06-145-S Production Sachets Incorrect variable data on sachet 
from S F104
Major P2ES Human error
Appendix I
P D R  N u m b e r O r ig i n a t i n g
D e p a r t m e n t
P r o d u c t
T y p e
B r i e f  D e s c r ip t i o n C a t e g o r y C l a s s i f i c a t i o n P r i m a r y  Root 
C a u s e
P D R -06-149-S Production Sachets Unsealed sachets found at start up 
at batch
Major P4ES Unknown
P D R -06-151-S Production Sachets Parts of sealing foam found in 
dosator filling Machine SF101
Critical P1EC Equipment
Failure
P D R -06 -152 -S Production Sachets Small rip in sachet Major P4ES Unknown
P D R 06-156-S Production Sachets Badly cut Sachets Major P4NS Unknown
P D R 06-157-S Production Sachets Badly Cut & unsealed sachets Major P4ES Unknown
P D R -06-158-S Production Sachets O O S  Batch Yield Minor P2EM Fluman error
P D R -06-160-S Production Sachets Wrong blend utilized in batch Minor P2HM Fluman error
P D R -06-161-S Production Sachets Screw found in carton at reject 
station
Minor P2HM Fluman error
T o t a l  N o . 
P D R s
1 5 9
T o t a l  N o . 
S a c h e t  P D R s
59
2 cancelled
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Appendix II
P D R  N u m b e r Department Product Type Brief Description Category Classification Primary Root 
Cause
P D R - 0 7 - 0 0 1 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  fo u n d  a t re je ct station M a jo r P 1 N S E q u ip m e n t
F a ilu re
P D R - 0 7 - 0 0 3 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e t fo u n d  in F 1  d u e  to u n e q u a l 
se a l a t to p  o f s a c h e t
M in o r P 1 H M E q u ip m e n t
Fa ilu re
P D R - 0 7 - 0 0 4 - S P ro d u c tio n S a c h e ts In co rre c t price o n  ca rto n M a jo r P 2 D S F lu m a n  E r r o r
P D R - 0 7 - 0 0 5 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e t d u e  to  lu m p  o f p o w d e r  fo u n d  
in fu n n e l
M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 0 0 8 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e t fo u n d  in P 2 M a jo r P 1 D S E q u ip m e n t
Fa ilu re
P D R - 0 7 - 0 1 0 - S P ro d u c tio n S a c h e ts D e -la m in a tin g  o f foil o n  filler S F 1 0 4 M a jo r P 4 N M U n k n o w n
P D R - 0 7 - 0 1 1 - S P ro d u c tio n S a c h e ts P r o b le m  w ith flo w  o f  b le n d  c a s u in g  erratic 
w e ig h ts
M a jo r P 4 N S U n k n o w n
P D R - 0 7 - 0 1 7 - S P ro d u c tio n S a c h e ts D u rin g  a  ro u tin e  c h e c k  Q A  d is c o v e re d  th a t th e  
e x p iry  d a te  o n  th e  s a c h e t foil a n d  th e  e x p iry  
d a te  o n  th e  c a rto n s  w h e re  d iffe re n t
M a jo r P 2 H S F lu m a n  E r r o r
P D R - 0 7 - 0 1 9 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e t fo u n d  in P 2 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 7 - 0 2 4 - S P ro d u c tio n S a c h e ts U n s e a le d  S a c h e t fo u n d  in P 2 M a jo r P 4 D S U n k n o w n
P D R - 0 7 - 0 2 5 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  d u e  to lu m p s  in ble nd M a jo r P 4 D S U n k n o w n
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P D R - 0 7 - 0 2 7 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e t fo u n d  in P 1 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 7 - 0 2 8 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  fo u n d  in F 1 / P 1 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 7 - 0 2 9 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  - lu m p s  in blend M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 0 3 3 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  P 2 M a jo r P 4 N S U n k n o w n
P D R - 0 7 - 0 3 4 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  fo u n d  P 1 / F 1 M in o r P 1  D M E q u ip m e n t
Fa ilu re
P D R - 0 7 - 0 3 7 - S P ro d u c tio n S a c h e ts S m a ll rip fo u n d  in s a c h e ts  in P 1  fro m  S F 1 0 1 M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 0 4 1 - S P ro d u c tio n S a c h e ts In co rrec t E x p ir y  d a te  u se d M in o r P 2 H M F lu m a n  E r r o r
P D R - 0 7 - 0 4 2 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  P 1 / F 1 M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 0 4 3 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  o n  S F 1 0 3  fo u n d  in F 2 / P 2 M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 0 4 4 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e t fo u n d  in P 1  a n d  F 1 M a jo r P 1 E S E q u ip m e n t
Fa ilu re
P D R - 0 7 - 0 4 6 - S Q u a lity
C o n tro l
S a c h e ts W e ig h t control a n d  c o n te n t a s s a y  issu e s M in o r Q 3 N M M a te rial
Q u a lity
P D R - 0 7 - 0 4 9 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  P 2 M a jo r P 4 E S U n k n o w n
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P D R - 0 7 - 0 5 0 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  S F 1 0 2  fo u n d  F 1 / P 1 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 7 - 0 5 1 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fro m  S F 1 0 3  &  S F 1 0 4  fo u n d  
F 2 / P 2
M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 0 5 2 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  o n  S F 1 0 1  a n d  S F 1 0 2  - F 1 / P 1 M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 0 5 3 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  P 1 M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 0 5 5 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 0 5 8 - S P ro d u c tio n S a c h e ts M issin g V a ria b le  d a ta  o n  c a to n s M a jo r P 2 E S F lu m a n  E rr o r
P D R - 0 7 - 0 6 1 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  in P 2 / B a d ly  cu t 
s a c h e ts  fo u n d  in P 2
M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 7 - 0 6 2 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  P 1 / F 1 M in o r P 2 E M F lu m a n  E r r o r
P D R - 0 7 - 0 6 3 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  fo u n d  in P 1 M in o r P 7 E M D e s ig n
L im ita tio n s
P D R - 0 7 - 0 6 4 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  S F 1 0 2 M in o r P 3 S M M aterial
Q u a lity
P D R - 0 7 - 0 6 7 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e t M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 0 6 8 - S P ro d u c tio n S a c h e ts V a ria b le  d a ta  m issin g  fro m  ca rto n M a jo r P 2 H M F lu m a n  E r r o r
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P D R - 0 7 - 0 6 9 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  in P 2 M in o r P 4 E S U n k n o w n
P D R - 0 7 - 0 7 0 - S P ro d u c tio n S a c h e ts U n s e a le d  S a c h e ts  fo u n d M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 7 - 0 7 1 - S P ro d u c tio n S a c h e ts V a ria b le  d a ta  print m issin g  o n  ca rto n M a jo r P 2 H S H u m a n  E rr o r
P D R - 0 7 - 0 7 2 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  in F 2 / P 2 M a jo r P I N S E q u ip m e n t
Fa ilu re
P D R - 0 7 - 0 7 3 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  in F 2 / P 2 M a jo r P I D S E q u ip m e n t
F a ilu re
P D R - 0 7 - 0 7 4 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  in F 2 / P 2 M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 0 7 5 - S P ro d u c tio n S a c h e ts U n s e a le d  S a c h e ts  F o u n d  fro m  S F 1 0 4 M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 0 7 8 - S P ro d u c tio n S a c h e ts B a d ly  c u t S a c h e ts  fo u n d  in P 1 / F 1  a t th e  reject 
c h e c k  w e ig h e r
M a jo r P 7 E S D e s ig n
Lim ita tio n s
P D R - 0 7 - 0 7 9 - S P ro d u c tio n S a c h e ts u n s e a le d  s a c h e ts  fo u n d  b y  o p e ra to r a t th e  
c h e c k w e ig h e r station P 2
M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 0 8 3 - S P ro d u c tio n S a c h e ts U n s e a le d , b a d ly  s e a le d  a n d  ta re s  o n  s a c h e ts M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 0 8 4 - S P ro d u c tio n S a c h e ts U n s e a le d  S a c h e ts  fo u n d  in F 1 M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 0 8 5 - S P ro d u c tio n S a c h e ts U n s e a le d  fo u n d  in F 1 o n  c o n v e y o r  belt M a jo r P 1 E S E q u ip m e n t
F a ilu re
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P D R - 0 7 - 0 8 6 - S Q A S a c h e ts S o m e  IP  c h e c k s  o m itte d M in o r P 2 T M H u m a n  E r r o r
P D R - 0 7 - 0 8 7 - S P ro d u c tio n S a c h e ts P a rtia lly filled s a c h e ts  fo u n d  in P 2 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 7 - 0 8 9 - S P ro d u c tio n S a c h e ts In tern al liner o f  C G S  F I B C  d a m a g e d M a jo r M 7 D S D e s ig n
Lim ita tio n s
P D R - 0 7 - 0 9 1 - S P ro d u c tio n S a c h e ts V a ria b le  d a ta  fro m  th e  c o d e  b lo ck w e re  to  be 
printed o n  c a rto n s  w ith ink b u t ink roller w a s  not 
p re s e n t o n  m a c h in e
M in o r P 2 H M H u m a n  E r r o r
P D R - 0 7 - 0 9 4 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  fo u n d  in P 1  a t c h e c k w e ig h e r M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 0 9 7 - S P ro d u c tio n S a c h e ts B a d ly  c u t S a c h e ts M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 0 9 8 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  fo u n d  in P 1  fro m  S F 1 0 2 M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 1 0 3 - S P ro d u c tio n S a c h e ts In co rre c t e x p iry  d a te  o n  c a rto n s M a jo r P 2 H S H u m a n  E r r o r
P D R - 0 7 - 1 0 4 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  in P 2 / F 2 M a jo r P 3 E S M a te rial
Q u a lity
P D R - 0 7 - 1 1 0 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  in P 1  fro m  S F 1 0 2 M a jo r P 2 E S H u m a n  E r r o r
P D R - 0 7 - 1 1 3 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  S F 1 0 2 M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 1 1 6 - S P ro d u c tio n S a c h e ts F r a g m e n t  o f  blue nitrate g lo v e  fo u n d  in C o m il 
mill a fte r d is p e n s in g  o f C G S  b a tch  0 7 2 9 7
M a jo r M 2 H S H u m a n  E r r o r
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P D R - 0 7 - 1 1 9 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e t fo u n d  in P 2  S F 0 1 4 M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 1 2 1 - S P ro d u c tio n S a c h e ts B a d ly  C u t  S a c h e ts M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 7 - 1 2 3 - S P ro d u c tio n  / 
T S
S a c h e ts P ie c e s  o f n ylo n  b a s e d  c a b le  fo u n d  in C o m il 
s ie v e  a fte r d is p e n s in g  o f C G S  I R L  0 7 2 3 7
M a jo r M 2 H S H u m a n  E r r o r
P D R - 0 7 - 1 2 6 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  on S F 1 0 4  a n d  later on 
S F 1 0 3
M a jo r P 3 E S M aterial
Q u a lity
P D R - 0 7 - 1 2 7 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  in rejection statio n  in 
P 2
M in o r P 3 E S M aterial
Q u a lity
P D R - 0 7 - 1 2 8 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  fo u n d  o n line 1 M a jo r P 1 H S E q u ip m e n t
Fa ilu re
P D R - 0 7 - 1 2 9 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  fo u n d  o n  line 1 S F 1 0 1 M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 1 3 2 - S P ro d u c tio n S a c h e ts U n s e a le d  S a c h e t fo u n d  in o u te r in P 2 M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 1 3 3 - S P ro d u c tio n S a c h e ts M issin g  print o n  ca rto n M in o r P 1 D M E q u ip m e n t
F a ilu re
P D R - 0 7 - 1 3 7 - S P ro d u c tio n S a c h e ts P a r t b ro k e n  o f c a rto n e r M in o r P 1 E M E q u ip m e n t
F a ilu re
P D R - 0 7 - 1 3 8 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  a n d  u n s e a le d  s a c h e ts  fo u n d  
in P 2
M a jo r P 4 E S U n k n o w n
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P D R - 0 7 - 1 4 0 - S P ro d u c tio n S a c h e ts B a d ly  c u t / torn s a c h e ts  a n d  p in c h e d  s a c h e ts  
fro m  S F 1 0 1
M a jo r P 1 H S E q u ip m e n t
F a ilu re
P D R - 0 7 - 1 4 1 - S P ro d u c tio n S a c h e ts T o r n  s a c h e t fo u n d  w h ile  c a rryin g  o u t IP  c h e c k M a jo r P 1 E S E q u ip m e n t
Fa ilu re
P D R - 0 7 - 1 4 3 - S P ro d u c tio n S a c h e ts B a d ly  cu t s a c h e ts  o n S F 1 0 3  S F 1 0 4 M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 1 4 4 - S P ro d u c tio n S a c h e ts B a d ly  cu t s a c h e ts  fo u n d  in P 2 M a jo r P 1 N S E q u ip m e n t
F a ilu re
P D R - 0 7 - 1 4 5 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e t fo u n d  in P 1  / F 1 M a jo r P 2 E S H u m a n  E r r o r
P D R - 0 7 - 1 4 7 - S P ro d u c tio n S a c h e ts R ip  a n d  sticky (w e t) stain  o n  s a c h e t fro m  
S F 1 0 4
M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 1 4 8 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e t fo u n d  in P 1 M a jo r P 2 E S H u m a n  E r r o r
P D R - 0 7 - 1 4 9 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  in P 2 M a jo r P 1 D S E q u ip m e n t
Fa ilu re
P D R - 0 7 - 1 5 1 - S P ro d u c tio n S a c h e ts T o r n  s a c h e t fo u n d  in P 1 M in o r P 1 E M E q u ip m e n t
F a ilu re
P D R - 0 7 - 1 5 4 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  fro m  S F 1 0 4 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 7 - 1 5 5 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  fro m  S F 1 0 3 M a jo r P 4 E S U n k n o w n
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P D R - 0 7 - 1 5 6 - S P ro d u c tio n S a c h e ts A  sm a ll length o f w ire  w a s  fo u n d  in th e  com ill 
d u rin g  a  ro u tin e  insp e c tio n
M a jo r M 1 H S E q u ip m e n t
F a ilu re
P D R - 0 7 - 1 5 8 - S P ro d u c tio n S a c h e ts T o r n  s a c h e t fo u n d  in c a rto n  in P 2  a n d  u n s e a le d  
S a c h e ts  fo u n d
M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 7 - 1 5 9 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  in S F 1 0 4 M a jo r P 1 E S E q u ip m e n t
Fa ilu re
P D R - 0 7 - 1 6 1 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  a lo n g  th e  pe rfo ra tio n  
o f tw in n e d  s a c h e t fro m  S F 1 0 4
M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 7 - 1 6 4 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e t fo u n d  in P 1 M a jo r P 2 E S H u m a n  E r r o r
P D R - 0 7 - 1 6 6 - S P ro d u c tio n S a c h e ts C G S  o v e r -d is p e n s e d , V a c u u m  tra n s fe r failure M in o r M 7 H M D e s ig n
Lim ita tio n s
P D R - 0 7 - 1 7 0 - S P ro d u c tio n S a c h e ts B a d ly  cu t s a c h e ts  fo u n d  fro m  S F 1 0 3 M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 1 7 3 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  in P 2 M in o r P 1 E S E q u ip m e n t
Fa ilu re
P D R - 0 7 - 1 7 5 - S P ro d u c tio n S a c h e ts  / 
blend
M e ta l pa rticle s fo u n d  in C o m il o n  c o m p le tio n  o f 
d is p e n s in g  o f G S  0 7 5 4 1
M a jo r M 1 E S E q u ip m e n t
Fa ilu re
P D R - 0 7 - 1 7 6 - S P ro d u c tio n S a c h e ts U n s e a le d  a n d  b a d ly  cu t s a c h e ts  fo u n d  in P 2 M a jo r P 4 E S U n k n o w n
P D R - 0 7 - 1 7 8 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e t fo u n d  in P 1  fro m  S F 1 0 1 M in o r P 2 E S H u m a n  E r r o r
P D R - 0 7 - 1 8 2 - S P ro d u c tio n S a c h e ts U n s e a le d  S a c h e ts  fo u n d  in F 2  P 2 M a jo r P 4 E S U n k n o w n
Appendix II
PDR Number Department Product Type Brief Description Category Classification Primary Root 
Cause
P D R - 0 7 - 1 8 6 - S P ro d u c tio n S a c h e ts B a tc h  b le n d e d  fo r 1 h o u r inste a d  o f 30 m in s M a jo r M 2 H S H u m a n  E r r o r
Total No. 
PDRs 187
Total No. 
Sachet PDRs 93
APPENDIX III
Appendix III
PDR Number Department Product
Type
Brief Description Category Classification Primary Root 
Cause
P D R - 0 8 - 0 0 8 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  in P 1  fro m  S f 1 01 M a jo r P 4 E S U n k n o w n
P D R - 0 8 - 0 1 4 - S P ro d u c tio n S a c h e ts B a d ly  cu t s a c h e ts  fo u n d  in P 2 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 0 1 5 - S Q u a lity
C o n tro l
S a c h e ts T h e  print e rro r o cc u rre d  c a u s in g  th e  batch 
n u m b e r to  b e  illegible
M in o r P 1 H M E q u ip m e n t
F a ilu re
P D R - 0 8 - 0 1 7 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e t fo u n d  in P 1  fro m  S F 1 0 2 M a jo r P 4 E S U n k n o w n
P D R - 0 8 - 0 2 4 - S P ro d u c tio n S a c h e ts S u c tio n  c u p  c a u s in g  d a m a g e  to  S a c h e t M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 0 2 5 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e t P 2 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 0 2 6 - S Q u a lity
A s s u r a n c e
S a c h e ts In co rrec t D O M  o n  c a rto n s M in o r P 2 H M H u m a n  E r r o r
P D R - 0 8 - 0 2 8 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e t fo u n d  in F 1 / P 1  a n d  s c re w  
fo u n d  in ca rto n
M a jo r P 2 E S H u m a n  E r r o r
P D R - 0 8 - 0 2 9 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e t fo u n d  in P 1 M a jo r P 3 E S M a te rial
Q u a lity
P D R - 0 8 - 0 3 0 - S P ro d u c tio n S a c h e ts T o r n  s a c h e t fro m  S F 1 0 1  in P 1 M in o r P 1 E M E q u ip m e n t
F a ilu re
P D R - 0 8 - 0 3 2 - S P ro d u c tio n S a c h e ts In co rre c t setting o n  c h e c k w e ig h e r M in o r P 2 T M H u m a n  E r r o r
Appendix III
PDR Number Department Product
Type
Brief Description Category Classification Primary Root 
Cause
P D R - 0 8 - 0 3 9 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e t fo u n d  in P 1 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 0 4 0 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e t fo u n d  in P 2 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 0 4 1 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e t fro m  S f 1 01 fo u n d  in P 1 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 0 4 3 - S P ro d u c tio n S a c h e ts B a d ly  cu t s a c h e ts  S F 1 0 2 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 0 4 4 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  S F 1 0 1  / S F 1 0 2 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 0 4 5 - S Q u a lity
C o n tro l
S a c h e ts L o w  o u t o f sp e cificatio n  re su lt fo r the 
g lu c o s a m in e  a s s a y .
M a jo r M 4 N S U n k n o w n
P D R - 0 8 - 0 4 8 - S P ro d u c tio n S a c h e ts B a d ly  s e a le d  s a c h e ts  fo u n d  in P 2  a t start up 
o f batch
M a jo r P 4 E S U n k n o w n
P D R - 0 8 - 0 4 9 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  fo u n d  in P 1  F l f r o m  S F 1 0 1 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 0 5 0 - S P ro d u c tio n S a c h e ts C h e c k w e ig h e r  re je cts n o t falling into reject 
bin
M in o r P 1 E M E q u ip m e n t
F a ilu re
P D R - 0 8 - 0 5 2 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  &  u n s e a le d  s a c h e t fro m  
S F 1 0 1
M a jo r P 4 E S U n k n o w n
Appendix III
PDR Number Department Product
Type
Brief Description Category Classification Primary Root 
Cause
P D R - 0 8 - 0 5 3 - S P ro d u c tio n S a c h e ts B a d ly  cu t s a c h e ts  fo u n d  fro m  S F 1 0 2 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 0 5 4 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  fro m  filling m a c h in e s  
S F 1 0 1  &  S F 1 0 2
M a jo r P 4 E S U n k n o w n
P D R - 0 8 - 0 5 7 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  fo u n d  in P 1 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 0 5 8 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  fo u n d  in P 2 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 0 6 1 - S Q u a lity
C o n tro l
S a c h e ts O O S  c o n te n t a s s a y s  o b ta in e d M in o r P 1 E S E q u ip m e n t
Fa ilu re
P D R - 0 8 - 0 6 3 - S P ro d u c tio n S a c h e ts U n s e a le d  S a c h e t fo u n d  in P 2  fro m  S F 1 0 4 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 0 6 7 - S P ro d u c tio n S a c h e ts B a tc h  w a s  s h o rt s a c h e ts  to finish M in o r P 1 E M E q u ip m e n t
Fa ilu re
P D R - 0 8 - 0 6 9 - S P ro d u c tio n S a c h e ts B a d ly  c u t &  u n s e a le d  s a c h e ts  fo u n d  in P 1 M in o r P 1 E S E q u ip m e n t
Fa ilu re
P D R - 0 8 - 0 7 0 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e t fo u n d  in P 1 M a jo r P 1 E S E q u ip m e n t
Fa ilu re
P D R - 0 8 - 0 7 1 - S Production S a c h e ts T ria ls  ca rrie d o u t du ring batch M in o r P 2 T M H u m a n  E r r o r
P D R - 0 8 - 0 7 9 - S P ro d u c tio n S a c h e ts U n s e a le d  S a c h e ts  fo u n d  in P 1 M a jo r P 2 H S H u m a n  E r r o r
Appendix III
PDR Number Department Product
Type
Brief Description Category Classification Primary Root 
Cause
P D R - 0 8 - 0 8 0 - S P ro d u c tio n S a c h e ts Fu ll c le a n s  o f ro o m  M 8  a re  d u e  e v e r y  7  d a y s . 
T h e  Fu ll cle an  o f  th e  ro o m  w a s  n o t c o m p le te d  
until 1 4  d a y s  h a d  e la p s e d .
M in o r M 2 H M H u m a n  E rr o r
P D R - 0 8 - 0 8 1 - S P ro d u c tio n S a c h e ts B a tc h  w a s  d is p e n s e d  a n d  b le n d e d  a s  a 
2 4 0 0 k g  blen d
M a jo r M 2 H S H u m a n  E rr o r
P D R - 0 8 - 0 8 5 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  fro m  S F  1 0 2  fo u n d  in P 1 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 0 8 6 - S P ro d u c tio n S a c h e ts W r o n g  C G S  u s e d  in S a c h e t B le n d  S 0 8 1 9 8 M a jo r M 2 H S H u m a n  E r r o r
P D R - 0 8 - 0 8 8 - S P ro d u c tio n S a c h e ts S c r e w  fo u n d  in ca rto n M in o r P 1 E M E q u ip m e n t
Fa ilu re
P D R - 0 8 - 0 8 9 - S P ro d u c tio n S a c h e ts U n s e a le d  S a c h e ts  fo u n d  in P 2  ( S F 1 0 3 ) M a jo r P 1 E M E q u ip m e n t
Fa ilu re
P D R - 0 8 - 0 9 2 - S P ro d u c tio n S a c h e ts A r e a  c le a ra n c e  fo r ro o m s  M 8  a n d  M 9  not 
s ig n e d  o ff
M in o r M 2 T M H u m a n  E r r o r
P D R - 0 8 - 0 9 5 - S P ro d u c tio n S a c h e ts O O S  Y ie ld  a n d  O O S  R e c o n c ilia tio n M in o r M 2 H M H u m a n  E r r o r
P D R - 0 8 - 0 9 6 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e t fo u n d  in P 1 M a jo r P 4 E S U n k n o w n
P D R - 0 8 - 0 9 7 - S P ro d u c tio n S a c h e ts W r o n g  a m o u n t o f P E G  4 0 0 0  d is p e n s e d  into 
b le n d  S 0 8 2 5 1 .
M in o r M 2 H M H u m a n  E r r o r
P D R - 0 8 - 0 9 8 - S P ro d u c tio n S a c h e ts P u n c tu r e d  s a c h e ts  fro m  F I M in o r M 1 E M E q u ip m e n t
F a ilu re
Appendix III
PDR Number Department Product
Type
Brief Description Category Classification Primary Root 
Cause
P D R - 0 8 - 0 9 9 - S P ro d u c tio n S a c h e ts H o is t c h a in  fell into b a g  o f C G S M a jo r M 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 1 0 0 - S P ro d u c tio n S a c h e ts In co rrec t identification label M in o r Q 2 H M H u m a n  E r r o r
P D R - 0 8 - 1 0 4 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e t fo u n d  in P 2 M a jo r P 4 E S U n k n o w n
P D R - 0 8 - 1 0 7 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts M a jo r P 2 E S H u m a n  E r r o r
P D R - 0 8 - 1 0 8 - S P ro d u c tio n S a c h e ts U n s e a le d  S a c h e ts M a jo r P 4 N S U n k n o w n
P D R - 0 8 - 1 0 9 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  a n d  m e tal stu d  fo u n d  in 
ca rto n
M a jo r P 1 E S E q u ip m e n t
Fa ilu re
P D R - 0 8 - 1 1 0 - S P ro d u c tio n S a c h e ts B a d ly  C u t  s a c h e t fo u n d  in P 1 M in o r P 2 E M H u m a n  E r r o r
P D R - 0 8 - 1 1 2 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts  S F 1 0 1 / S F 1 0 2 M a jo r P 4 E S U n k n o w n
P D R - 0 8 - 1 1 3 - S P ro d u c tio n S a c h e ts T w o  inc ide n ts o f U n s e a le d  s a c h e ts  fo u n d  in 
P 2
M a jo r P 2 N S H u m a n  E r r o r
P D R - 0 8 - 1 1 5 - S P ro d u c tio n S a c h e ts D a m a g e d  c a rto n  w ith torn s a c h e t p a s s in g  
into c a s e -p a c k e r
M in o r P 1 E M E q u ip m e n t
F a ilu re
P D R - 0 8 - 1 2 0 - S Q u a lity
C o n tro l
S a c h e ts S a c h e ts  fro m  filler S F 1 0 3 ,  2 5 %  c o n ta in e d  
cutting e rro r. D o s a to r  n u m b e r m issin g .
M in o r Q 2 T M H u m a n  E r r o r
P D R - 0 8 - 1 2 1 - S Q u a lity
C o n tro l
S a c h e ts E x p ir y  d a te  illegible o n  s a c h e t b o x M in o r P 4 E M U n k n o w n
Appendix III
P D R  N u m b e r D e p a r t m e n t P r o d u c t
Type
B r i e f  D e s c r ip t i o n Category Classification Primary Root 
Cause
P D R - 0 8 - 1 2 4 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e ts  fo u n d  in P 1 M in o r P 4 E M U n k n o w n
P D R - 0 8 - 1 2 5 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e t d u e  to  o b s tru c tio n  in 
F u n n e l.
M in o r P 2 H M H u m a n  E r r o r
P D R - 0 8 - 1 2 6 - S P ro d u c tio n S a c h e ts In co rre c t batch n u m b e r  issu e d  fo r D o n a  4 ’s 
bulk s a c h e ts
M in o r Q 2 T M H u m a n  E r r o r
P D R - 0 8 - 1 2 8 - S P ro d u c tio n S a c h e ts T o r n  s a c h e t lea din g to  lea kin g p o w d e r M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 1 3 2 - S P ro d u c tio n S a c h e ts W r o n g  e x p iry  d a te  o n s a c h e ts  fro m  filler 
S F 1 0 3
M in o r P 2 H M H u m a n  E rr o r
P D R - 0 8 - 1 3 3 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e t fo u n d  in P 1 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 1 3 4 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e t fo u n d  in P 1 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 1 3 5 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e t fo u n d  o n S F 1 0 1  a n d  S F 1 0 2 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 1 3 7 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e ts M in o r P 2 H M H u m a n  E r r o r
P D R - 0 8 - 1 3 8 - S P ro d u c tio n S a c h e ts U n s e a le d  s a c h e t d u e  to  vib ra tio n  control 
v a lv e  n o t o p e n in g  fully
M a jo r P 1 E S E q u ip m e n t
F a ilu re
Appendix III
PDR Number Department Product
Type
Brief Description Category Classification Primary Root 
Cause
P D R - 0 8 - 1 4 3 - S P ro d u c tio n S a c h e ts T h e  re q u ire m e n t fo r th e  *  to b e  printed on 
s a c h e ts  fro m  S F 1 0 3  fo r C lin ical T ria ls  
b a tc h e s  is n o t n e c e s s a ry .
M a jo r P 2 H S H u m a n  E r r o r
P D R - 0 8 - 1 4 4 - S P ro d u c tio n S a c h e ts T e c h  w o rk in g  in F 2  o n  se a lin g  p late  issu e s. 
T h e  se a lin g p la te s o n  S F 1 0 3  w o u ld  n o t clo se  
d u e  to a pin o u t o f pla c e .
M in o r P 2 D M H u m a n  E r r o r
P D R - 0 8 - 1 4 6 - S P ro d u c tio n S a c h e ts B a d ly  C u t  s a c h e t fo u n d  in P 1 M in o r P 4 E M U n k n o w n
P D R - 0 8 - 1 4 9 - S Q u a lity
C o n tro l
S a c h e ts B la c k  m a rk s  w e re  fo u n d  o n  S a c h e ts  fro m  
b a tch  B - 7 5
M a jo r P 2 E S H u m a n  E r r o r
P D R - 0 8 - 1 5 0 - S P ro d u c tio n S a c h e ts U n s e a le d  S a c h e ts  fro m  Fille r S F 1 0 4 M in o r P 1 H M E q u ip m e n t
Fa ilu re
P D R - 0 8 - 1 5 1 - S Q u a lity
A s s u r a n c e
S a c h e ts N o  s e c o n d  c h e c k s  o n d is p e n s in g M in o r M 2 H M H u m a n  E r r o r
P D R - 0 8 - 1 5 2 - S P ro d u c tio n S a c h e ts U n s e a le d  S a c h e t fo u n d  In P 2  a t the 
c h e c k w e ig h e r
M a jo r P 1 E S E q u ip m e n t
Fa ilu re
P D R - 0 8 - 1 5 3 - S P ro d u c tio n S a c h e ts S m u d g e d  print o n v a ria b le  c o d e  o n  s a c h e ts  
fro m  S F 1 0 3
M in o r P 2 E M H u m a n  E r r o r
P D R - 0 8 - 1 5 6 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e t fro m  S F 1 0 1  fo u n d  in P 1 M a jo r P 1 E S E q u ip m e n t
F a ilu re
P D R - 0 8 - 1 5 7 - S E n g in e e rin g S a c h e ts U n d e r  d is p e n s in g  o f P la n ta g o  O v a t a  into th e  
blend
M a jo r M 2 H S H u m a n  E r r o r
Appendix III
PDR Number Department Product
Type
Brief Description Category Classification Primary Root 
Cause
P D R - 0 8 - 1 6 3 - S P ro d u c tio n S a c h e ts T o r n  s a c h e t fro m  S F 1 0 2  fo u n d  in P 1 M a jo r P 1 S S E q u ip m e n t
F a ilu re
P D R - 0 8 - 1 6 4 - S P ro d u c tio n S a c h e ts B a d ly  c u t s a c h e t fro m  S F 1 0 1 M a jo r P 1 N S E q u ip m e n t
Fa ilu re
Total No. 
PDRs 163
Total No. 
Sachet PDRs 77
1 cancelled
8
